missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Chemicals
  4. Organic compounds
  5. Organoheterocyclic compounds
  6. Pyridines and derivatives
  7. GSK 2830371, MedChemExpress

GSK 2830371, MedChemExpress

Product Code. 16459397
Encompass_Preferred
Click to view available options
Quantity:
5 mg
10 mg
50 mg
100 mg
200 mg
Unit Size:
100mg
10mg
200mg
50mg
5mg
This item is not returnable. View return policy

Product Code. 16459397

Brand: Medchem Express HY15832

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

MedChemExpress GSK 2830371 is a highly selective Wip1 phosphatase inhibitor with IC50 of 6 nM.

GSK 2830371 is a highly selective Wip1 phosphatase inhibitor with IC50 of 6 nM.

Specifications

Chemical Name or Material GSK 2830371
CAS 1404456-53-6
Color Off-White
Purity Grade Notes Research
Molecular Formula C23H29ClN4O2S
Quantity 5 mg
Solubility Information DMSO : ≥ 51 mg/mL (110.62 mM)
SMILES ClC1=CN=C(C)C(NCC2=CC=C(C(N[C@@H](CC3CCCC3)C(NC4CC4)=O)=O)S2)=C1
Molecular Weight (g/mol) 461.02
Formula Weight 461.02
Percent Purity 98.03%
Grade Research
Physical Form Solid
For Use With (Application) Cancer-Kinase/protease
Show More Show Less

Research purposes only

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.